How much has Avelios raised?

Avelios has disclosed a €30M Series A led by Sequoia Capital in February 2025, alongside existing investors Revent and HTGF. Third-party startup profiles also reference an earlier approximately €2M seed round from Revent and HTGF, but the Series A is the major public financing event.

The investor or owner set is described in the public capital history. Sequoia provenance is included where Sequoia lists Avelios in its official company database, and this profile avoids filling undisclosed investor allocations.

For Avelios, valuation is either public-market/acquisition based or not disclosed. The responsible interpretation is to use disclosed transaction values and status, not extrapolated private marks.

Profitability and IPO timing are not disclosed unless public filings say otherwise. Sellers should use stage, ownership, and operating milestones as budget signals.

The funding or ownership context points to active budgets in the areas directly tied to Healthcare IT: product, compliance, infrastructure, data, and go-to-market systems. A useful pitch should map to measurable operational outcomes rather than generic growth claims.